InvestorsHub on MSN

Novavax shares gain after Matrix-M adjuvant licensing deal with Pfizer

Novavax (NASDAQ:NVAX) shares climbed about 5% on Tuesday after the biotech group disclosed a non-exclusive licensing ...

JPM26: Matrix-M Technology is central to Novavax’s strategy

Novavax’s CEO reviewed the company’s successes in 2025 and shared its growth strategy for 2026 and beyond at a recent ...
WFLA News Channel 8

DG Matrix Unveils Breakthrough Technology for Multi-Billion-Dollar EV Charging, Microgrid, and GenAI Datacenter Markets

DG Matrix announces the first field deployment of its breakthrough Power Router technology to accelerate global electrification and alleviate grid constraints. In a bold move to leapfrog the entire ...
Business Wire

Imbed Biosciences Announces FDA IDE Approval for Silver-Gallium Synthetic Antimicrobial Matrix Clinical Study with Human Donor Site Wounds

MIDDLETON, Wis.--(BUSINESS WIRE)--Imbed Biosciences (“Imbed”), a pioneer in breakthrough wound care synthetic matrix technology, today announced the U.S. Food and Drug Administration (FDA) has ...